Heterotypic contact reveals a COX-2-mediated suppression of osteoblast differentiation by endothelial cells: A negative modulatory role for prostanoids in VEGF-mediated cell: cell communication?

Experimental Cell Research
Claire E ClarkinCaroline P D Wheeler-Jones

Abstract

In bone, angiogenesis must be initiated appropriately, but limited once remodelling or repair is complete. Our recent findings have supported a role for prostaglandins (PG), known modulators of osteoblast (OB) and endothelial cell (EC) behaviour, in facilitating VEGF-mediated paracrine communication from OBs to 'remotely located' ECs, but the mechanism(s) regulating OB:EC crosstalk when these cells are closely opposed are undefined. In this study we have examined: (i) the effects of exogenous PGE(2) on VEGF-driven events in ECs, and (ii) the role of endogenous COX-2-derived prostanoids in mediating communication between intimately opposed OBs and ECs in direct contact. Exposure of ECs to PGE(2) increased ERK1/2 phosphorylation, COX-2 induction, 6-keto-PGF(1alpha) release and EC proliferation. In contrast, PGE(2) attenuated VEGF(165)-induced VEGFR2/Flk1 phosphorylation, ERK1/2 activation and proliferation of ECs, suggesting that exogenous PGE(2) restricts the actions of VEGF. However, the COX-2-selective inhibitor, NS398, also attenuated VEGF-induced proliferation, implying a distinct role for endogenous COX-2 activity in regulating EC behaviour. To examine the effect of OB:EC proximity and the role of COX-2 products further, we...Continue Reading

Citations

Apr 5, 2014·Archivum Immunologiae Et Therapiae Experimentalis·Yanqiu Liu, Bjorn R Olsen
Jul 20, 2011·Annals of Biomedical Engineering·Amita R ShahC Mauli Agrawal
Nov 7, 2012·Cell Biochemistry and Function·Claire E Clarkin, Louis C Gerstenfeld
Apr 17, 2013·International Immunopharmacology·Yan BaiXiming Pu
Dec 14, 2011·PloS One·Cristina CorreiaGordana Vunjak-Novakovic
Nov 14, 2018·Tissue Engineering. Part a·Brittany TaylorJoseph Freeman
Nov 23, 2018·Calcified Tissue International·Vimal VeeriahMattia Capulli
Nov 17, 2009·Biochemical Society Transactions·Caroline P D Wheeler-JonesElena Garonna
Feb 4, 2011·Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine·R S TareR O C Oreffo
Dec 31, 2020·Stem Cells Translational Medicine·Stefano NegriAaron W James
Feb 19, 2021·Tissue Engineering. Part a·Nicholas G Schott, Jan P Stegemann
Jul 28, 2020·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Youjia DuPeter Zahradka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.